MedTrace Logo

Study on Tear Proteins in Diabetic Retinopathy of Type 2 Diabetics

NCT00698698 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2009-02-02

No results posted yet for this study

Summary

Diabetes mellitus is becoming a global epidemic. There is a need to devise a non invasive method for detection of diabetes and its related complication. Tear proteins are easy to collect causing no harm to a patient and different studies indicate that tear proteins of diabetic patients are significantly different from non diabetic population. This difference in the composition of tear proteins become more pronounced with advancement of diabetic retinopathy.

Conditions

Sponsors & Collaborators

  • Dow University of Health Sciences

    lead OTHER

Principal Investigators

  • Dr. Jamshed Ahmed, FCPS · Dow University of Health Sciences Pakistan

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-12-31
Completion
2011-06-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00698698 on ClinicalTrials.gov